Location: New York, NY
CIK: 0001814465 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $348M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 2,851,449 | $98.35M | 28.3% | $8.91 | +219.5% | COM NEW | 53635D202 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 1,130,460 | $82.39M | 23.7% | $39.05 | +54.6% | COM | G31249108 |
| LQDA | LIQUIDIA CORPORATION | 1,200,000 | $41.39M | 11.9% | $8.91 | +219.5% | Put | 53635D202 |
| ROOT | ROOT INC | 235,000 | $16.97M | 4.9% | $93.90 | -15.2% | CL A NEW | 77664L207 |
| DAVE | DAVE INC | 70,000 | $15.5M | 4.5% | $215.57 | -0.2% | CLASS A COM NEW | 23834J201 |
| TPB | TURNING PT BRANDS INC | 127,000 | $13.77M | 4.0% | $92.64 | +5.5% | COM | 90041L105 |
| OPRT | OPORTUN FINL CORP | 2,568,300 | $13.59M | 3.9% | $3.75 | +40.7% | COM | 68376D104 |
| SGHC | SUPER GROUP SGHC LIMITED | 940,000 | $11.23M | 3.2% | $11.84 | +1.5% | ORD SHS | G8588X103 |
| GEO | GEO GROUP INC NEW | 650,000 | $10.48M | 3.0% | $23.17 | -28.0% | COM | 36162J106 |
| CELH | CELSIUS HLDGS INC | 210,000 | $9.605M | 2.8% | $50.38 | 0.0% | COM NEW | 15118V207 |
| EHTH | EHEALTH INC | 1,408,975 | $6.481M | 1.9% | $7.25 | -39.2% | COM | 28238P109 |
| ABVX | ABIVAX SA | 48,000 | $6.473M | 1.9% | $93.23 | — | SPONSORED ADS | 00370M103 |
| LRN | STRIDE INC | 90,000 | $5.844M | 1.7% | $90.80 | 0.0% | COM | 86333M108 |
| ADMA | ADMA BIOLOGICS INC | 300,000 | $5.472M | 1.6% | $16.85 | 0.0% | COM | 000899104 |
| LQDA | LIQUIDIA CORPORATION | 156,000 | $5.38M | 1.5% | $8.91 | +219.5% | Call | 53635D202 |
| VOR | VOR BIOPHARMA INC | 231,000 | $3.021M | 0.9% | $18.62 | 0.0% | COM NEW | 929033207 |
| MLYS | MINERALYS THERAPEUTICS INC | 50,000 | $1.815M | 0.5% | $21.63 | +85.4% | COM | 603170101 |